RNAi silencing of exogenous and endogenous reporter genes using a macrocyclic octaamine as a "compact" siRNA carrier. Studies on the nonsilenced residual activity

Kazuki Matsui, Shohei Horiuchi, Shinsuke Sando, Takashi Sera, Yasuhiro Aoyama

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

A macrocyclic octaamine 1 having a covalently linked lipid-bundle structure was introduced as a new type of siRNA carrier. Gel electrophoresis, DLS, and SPR results indicate that it strongly binds to a luciferase-targeting 21-mer (42P) siRNA with a ratio of 1/P ≅ 0.3 (1/N ≅ 2.4) to give remarkably compact 1-siRNA complexes with an average size of ∼10 nm. The 1-mediated siRNA silencing of the exogenous luciferase gene occurs with a 90-95% efficiency. The overall suppression-[siRNA] profile with a 5-10% residual activity in the saturation region is commonly observed irrespective of the cell type (HeLa, HepG2, or HEK293), the order, or timing (stepwise or simultaneous) of supply of the siRNA and that of the luciferase-encoding plasmid, the level of mRNA transcribed, or the type of carriers (1 vs lipofectamine 2000). The silencing of the endogenous DsRed2 gene stably incorporated in the genome of HeLa cells also has a similar overall profile. These results suggest that (1) the cellular uptake of the plasmid and that of the siRNA are basically independent of each other and (2) the incomplete silencing is not due to insufficient siRNA delivery. Implication of item 2 is briefly discussed.

Original languageEnglish
Pages (from-to)132-138
Number of pages7
JournalBioconjugate Chemistry
Volume17
Issue number1
DOIs
Publication statusPublished - Jan 2006
Externally publishedYes

Fingerprint

RNA Interference
Reporter Genes
Small Interfering RNA
Genes
Luciferases
Electrophoresis
Lipids
Gels
HeLa Cells
Plasmids
HEK293 Cells
Hep G2 Cells
Genome
Messenger RNA

ASJC Scopus subject areas

  • Chemistry(all)
  • Organic Chemistry
  • Clinical Biochemistry
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry

Cite this

RNAi silencing of exogenous and endogenous reporter genes using a macrocyclic octaamine as a "compact" siRNA carrier. Studies on the nonsilenced residual activity. / Matsui, Kazuki; Horiuchi, Shohei; Sando, Shinsuke; Sera, Takashi; Aoyama, Yasuhiro.

In: Bioconjugate Chemistry, Vol. 17, No. 1, 01.2006, p. 132-138.

Research output: Contribution to journalArticle

@article{0608c154489d497ab0b9baaecc75868d,
title = "RNAi silencing of exogenous and endogenous reporter genes using a macrocyclic octaamine as a {"}compact{"} siRNA carrier. Studies on the nonsilenced residual activity",
abstract = "A macrocyclic octaamine 1 having a covalently linked lipid-bundle structure was introduced as a new type of siRNA carrier. Gel electrophoresis, DLS, and SPR results indicate that it strongly binds to a luciferase-targeting 21-mer (42P) siRNA with a ratio of 1/P ≅ 0.3 (1/N ≅ 2.4) to give remarkably compact 1-siRNA complexes with an average size of ∼10 nm. The 1-mediated siRNA silencing of the exogenous luciferase gene occurs with a 90-95{\%} efficiency. The overall suppression-[siRNA] profile with a 5-10{\%} residual activity in the saturation region is commonly observed irrespective of the cell type (HeLa, HepG2, or HEK293), the order, or timing (stepwise or simultaneous) of supply of the siRNA and that of the luciferase-encoding plasmid, the level of mRNA transcribed, or the type of carriers (1 vs lipofectamine 2000). The silencing of the endogenous DsRed2 gene stably incorporated in the genome of HeLa cells also has a similar overall profile. These results suggest that (1) the cellular uptake of the plasmid and that of the siRNA are basically independent of each other and (2) the incomplete silencing is not due to insufficient siRNA delivery. Implication of item 2 is briefly discussed.",
author = "Kazuki Matsui and Shohei Horiuchi and Shinsuke Sando and Takashi Sera and Yasuhiro Aoyama",
year = "2006",
month = "1",
doi = "10.1021/bc050112l",
language = "English",
volume = "17",
pages = "132--138",
journal = "Bioconjugate Chemistry",
issn = "1043-1802",
publisher = "American Chemical Society",
number = "1",

}

TY - JOUR

T1 - RNAi silencing of exogenous and endogenous reporter genes using a macrocyclic octaamine as a "compact" siRNA carrier. Studies on the nonsilenced residual activity

AU - Matsui, Kazuki

AU - Horiuchi, Shohei

AU - Sando, Shinsuke

AU - Sera, Takashi

AU - Aoyama, Yasuhiro

PY - 2006/1

Y1 - 2006/1

N2 - A macrocyclic octaamine 1 having a covalently linked lipid-bundle structure was introduced as a new type of siRNA carrier. Gel electrophoresis, DLS, and SPR results indicate that it strongly binds to a luciferase-targeting 21-mer (42P) siRNA with a ratio of 1/P ≅ 0.3 (1/N ≅ 2.4) to give remarkably compact 1-siRNA complexes with an average size of ∼10 nm. The 1-mediated siRNA silencing of the exogenous luciferase gene occurs with a 90-95% efficiency. The overall suppression-[siRNA] profile with a 5-10% residual activity in the saturation region is commonly observed irrespective of the cell type (HeLa, HepG2, or HEK293), the order, or timing (stepwise or simultaneous) of supply of the siRNA and that of the luciferase-encoding plasmid, the level of mRNA transcribed, or the type of carriers (1 vs lipofectamine 2000). The silencing of the endogenous DsRed2 gene stably incorporated in the genome of HeLa cells also has a similar overall profile. These results suggest that (1) the cellular uptake of the plasmid and that of the siRNA are basically independent of each other and (2) the incomplete silencing is not due to insufficient siRNA delivery. Implication of item 2 is briefly discussed.

AB - A macrocyclic octaamine 1 having a covalently linked lipid-bundle structure was introduced as a new type of siRNA carrier. Gel electrophoresis, DLS, and SPR results indicate that it strongly binds to a luciferase-targeting 21-mer (42P) siRNA with a ratio of 1/P ≅ 0.3 (1/N ≅ 2.4) to give remarkably compact 1-siRNA complexes with an average size of ∼10 nm. The 1-mediated siRNA silencing of the exogenous luciferase gene occurs with a 90-95% efficiency. The overall suppression-[siRNA] profile with a 5-10% residual activity in the saturation region is commonly observed irrespective of the cell type (HeLa, HepG2, or HEK293), the order, or timing (stepwise or simultaneous) of supply of the siRNA and that of the luciferase-encoding plasmid, the level of mRNA transcribed, or the type of carriers (1 vs lipofectamine 2000). The silencing of the endogenous DsRed2 gene stably incorporated in the genome of HeLa cells also has a similar overall profile. These results suggest that (1) the cellular uptake of the plasmid and that of the siRNA are basically independent of each other and (2) the incomplete silencing is not due to insufficient siRNA delivery. Implication of item 2 is briefly discussed.

UR - http://www.scopus.com/inward/record.url?scp=31544474910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31544474910&partnerID=8YFLogxK

U2 - 10.1021/bc050112l

DO - 10.1021/bc050112l

M3 - Article

VL - 17

SP - 132

EP - 138

JO - Bioconjugate Chemistry

JF - Bioconjugate Chemistry

SN - 1043-1802

IS - 1

ER -